Who is sponsoring NCT05786807?

NCT05786807 is sponsored by Wonkwang University Hospital.

What drugs are being tested in NCT05786807?

Interventions in NCT05786807: K-CAB.

What condition does NCT05786807 study?

NCT05786807 studies Helicobacter Pylori-positive With Functional Dyspepsia.

Is NCT05786807 still recruiting?

NCT05786807 is currently status unknown. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT05786807

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients

Status unknown Phase 4 Last updated 28 March 2023

What this trial tests

Phase 4 trial testing K-CAB in Helicobacter Pylori-positive With Functional Dyspepsia in 315 participants. Status unknown.

Timeline

7 March 2022

Primary endpoint
30 November 2023

31 December 2023

Quick facts

Lead sponsor	Wonkwang University Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	315
Start date	7 March 2022
Primary completion	30 November 2023
Estimated completion	31 December 2023
Sites	1 location across South Korea

Drugs / interventions tested

K-CAB — full drug profile →

Conditions studied

Helicobacter Pylori-positive With Functional Dyspepsia — all drugs for Helicobacter Pylori-positive With Functional Dyspepsia →

Sponsor

Wonkwang University Hospital

Who can join

Adults 19 to 75, any sex, with Helicobacter Pylori-positive With Functional Dyspepsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patients with Helicobacter pylori-positive functional dyspepsia, long-term follow-up for 6 months after standard triple therapy first-line eradication treatment, the rate of symptom disappearance and degree of improvement of functional dyspepsia were confirmed through changes in symptom scores and changes in drug usage, and eradication treatment The purpose of this study is to confirm the rate of symptom disappearance according to the results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Wonkwang University Hospital trials

Trials by the same sponsor.

NCT07389954 — Personalized Music and Dreaming During Propofol Sedation · NA · completed
NCT07360262 — Gastric Emptying Recovery After GLP-1 RA Cessation · completed
NCT07260890 — Paired Comparison of SVV and PVI Accuracy · recruiting
NCT06970249 — Music Timing for Emergence Delirium in Elderly · NA · completed
NCT07097454 — Effectiveness of Hypotension Prediction Index (HPI) in Preventing Hypotension in the Post-Anesthesia Care Unit (PACU) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05786807 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wonkwang University Hospital
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05786807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing